Evidence for Suppressor Cell Activity Associated with Depression of Contact Sensitivity in Pseudomonas Aeruginosa Infected Mice
Overview
Authors
Affiliations
Pseudomonas aeruginosa infection depresses contact sensitivity to 2-phenyl-4-ethoximethylene-oxazolone (oxazolone), and enhances the antibody response to sheep erythrocytes (SRBC) in the mouse. Anti-oxazolone antibody titres were found not to be significantly different in infected and uninfected animals; thus, the major circulating classes of antibodies do not seem to be responsibile for the observed depression of skin reactivity. Low dose (20 mg/Kg) cyclophosphamide (CY) pretreatment induced a further potentiation of antibody response to SRBC, and prevented depression of contact sensitivity in infected mice. On the other hand, when infected animals were pretreated with high doses (200 mg/Kg) of CY, antibody production was completely suppressed, whereas contact sensitivity was unaffected. Since CY treatment is known to selectively inhibit B lymphocytes, and since it can abrogate the infection-induced depression of reactivity to oxazolone, it is suggested that suppressor cells, which may have B-cell characteristics, are stimulated during P. aeruginosa infection in the mouse.
Cell-mediated immunity and delayed-type hypersensitivity in Pseudomonas aeruginosa-infected mice.
Campa M, Toca L, Lombardi S, Garzelli C, Colizzi V, Falcone G Med Microbiol Immunol. 1982; 170(3):191-9.
PMID: 7078523 DOI: 10.1007/BF02298199.
Garzelli C, Colizzi V, Campa M, Falcone G Med Microbiol Immunol. 1980; 168(2):111-8.
PMID: 6779101 DOI: 10.1007/BF02121759.
Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A.
Holt P, Misfeldt M Infect Immun. 1984; 45(1):227-33.
PMID: 6429047 PMC: 263305. DOI: 10.1128/iai.45.1.227-233.1984.
Garzelli C, Colizzi V, Campa M, Bozzi L, Falcone G Infect Immun. 1979; 26(1):4-11.
PMID: 159263 PMC: 414565. DOI: 10.1128/iai.26.1.4-11.1979.
Colizzi V, Campa M, Garzelli C, Falcone G Med Microbiol Immunol. 1979; 167(3):181-8.
PMID: 158702 DOI: 10.1007/BF02121184.